Production (Stage)
Zomedica Corp.
ZOMDF
$0.047
-$0.0022-4.47%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.50M | 7.90M | 7.00M | 6.13M | 6.26M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.50M | 7.90M | 7.00M | 6.13M | 6.26M |
| Cost of Revenue | 2.09M | 2.35M | 1.94M | 1.77M | 2.15M |
| Gross Profit | 4.41M | 5.55M | 5.06M | 4.36M | 4.12M |
| SG&A Expenses | 11.27M | 11.56M | 10.66M | 11.90M | 12.73M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.22M | 16.06M | 14.44M | 15.17M | 16.65M |
| Operating Income | -8.72M | -8.16M | -7.44M | -9.04M | -10.39M |
| Income Before Tax | -63.87M | -7.42M | -6.72M | -24.07M | -9.33M |
| Income Tax Expenses | -57.00K | -221.00K | -27.00K | -143.00K | -166.00K |
| Earnings from Continuing Operations | -63.81M | -7.19M | -6.70M | -23.93M | -9.16M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -63.81M | -7.19M | -6.70M | -23.93M | -9.16M |
| EBIT | -8.72M | -8.16M | -7.44M | -9.04M | -10.39M |
| EBITDA | -6.50M | -6.11M | -5.41M | -7.07M | -8.46M |
| EPS Basic | -0.07 | -0.01 | -0.01 | -0.02 | -0.01 |
| Normalized Basic EPS | -0.01 | 0.00 | 0.00 | -0.01 | -0.01 |
| EPS Diluted | -0.07 | -0.02 | -0.01 | -0.02 | -0.01 |
| Normalized Diluted EPS | -0.01 | 0.00 | 0.00 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 979.95M | 979.95M | 979.95M | 979.95M | 979.95M |
| Average Diluted Shares Outstanding | 979.95M | 979.95M | 979.95M | 979.95M | 979.95M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |